Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEROTRALSTAT vs HUMAN C1-ESTERASE INHIBITOR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BEROTRALSTAT vs HUMAN C1-ESTERASE INHIBITOR: Safety Overview

Metric BEROTRALSTAT HUMAN C1-ESTERASE INHIBITOR
Total FAERS Reports 548 14,344
Deaths Reported 24 1,403
Death Rate 4.4% 9.8%
Hospitalizations 128 3,966
Average Patient Age 45.9 yrs 42.7 yrs
% Female Patients 74.7% 79.1%
FDA Approval Date Dec 11, 2025 N/A
Manufacturer BioCryst Pharmaceuticals, Inc. Takeda Pharmaceuticals America, Inc.
Route ORAL N/A
Marketing Status Prescription N/A